Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matt Kalaycio

Showing results (11-20 of 155) with videos related to

Pageof 16
Sort By:
Leukemia & Lymphoma|December 14, 2011
Targeted therapy for patients with chronic myeloid leukemia: clinical trial experience and challenges in inter-trial comparisonsRamon Tiu, Matt Kalaycio
Oncotargets and Therapy|September 15, 2015
Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemiaBrian T Hill, Matt Kalaycio
Clinical Advances in Hematology & Oncology : H&O|January 16, 2010
Review: what causes neurotoxicity after exposure to purine analogs?Matt Kalaycio, Clemens M Wendtner
Current Hematologic Malignancy Reports|April 29, 2010
The role of gemtuzumab ozogamicin in combination chemotherapy regimens for primary resistant or relapsed acute myeloid leukemiaHien K Duong, Matt Kalaycio
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 29, 2014
Maximizing the benefits of mycophenolate mofetil as graft-versus-host disease prophylaxisBetty Ky Hamilton, Matt Kalaycio
Current Treatment Options in Oncology|May 5, 2005
Prolymphocytic leukemiaAhmed Absi, Eric Hsi, Matt Kalaycio
Current Hematologic Malignancy Reports|April 29, 2010
The role of parenteral nutrition in acute leukemiaNicole B Jacobson, Neha Parekh, Matt Kalaycio
JAMA Oncology|March 12, 2016
Perspectives in Oncology Drug PricingJames P Stevenson, Matt Kalaycio, Brian Bolwell
Cleveland Clinic Journal of Medicine|December 28, 2006
The clinical picture. A woman with aplastic anemia and a rashIla Tamaskar, Ena Segota, Matt Kalaycio, et al.
Cancer|May 19, 2006
Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhageSujith Kalmadi, Ramon Tiu, Christopher Lowe, et al.
Pageof 16

Showing results (11-20 of 155) with videos related to

Sort By:
Pageof 16
Leukemia & Lymphoma|December 14, 2011
Targeted therapy for patients with chronic myeloid leukemia: clinical trial experience and challenges in inter-trial comparisonsRamon Tiu, Matt Kalaycio
Oncotargets and Therapy|September 15, 2015
Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemiaBrian T Hill, Matt Kalaycio
Clinical Advances in Hematology & Oncology : H&O|January 16, 2010
Review: what causes neurotoxicity after exposure to purine analogs?Matt Kalaycio, Clemens M Wendtner
Current Hematologic Malignancy Reports|April 29, 2010
The role of gemtuzumab ozogamicin in combination chemotherapy regimens for primary resistant or relapsed acute myeloid leukemiaHien K Duong, Matt Kalaycio
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 29, 2014
Maximizing the benefits of mycophenolate mofetil as graft-versus-host disease prophylaxisBetty Ky Hamilton, Matt Kalaycio
Current Treatment Options in Oncology|May 5, 2005
Prolymphocytic leukemiaAhmed Absi, Eric Hsi, Matt Kalaycio
Current Hematologic Malignancy Reports|April 29, 2010
The role of parenteral nutrition in acute leukemiaNicole B Jacobson, Neha Parekh, Matt Kalaycio
JAMA Oncology|March 12, 2016
Perspectives in Oncology Drug PricingJames P Stevenson, Matt Kalaycio, Brian Bolwell
Cleveland Clinic Journal of Medicine|December 28, 2006
The clinical picture. A woman with aplastic anemia and a rashIla Tamaskar, Ena Segota, Matt Kalaycio, et al.
Cancer|May 19, 2006
Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhageSujith Kalmadi, Ramon Tiu, Christopher Lowe, et al.
Pageof 16